학술논문
Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response
Document Type
Article
Author
Source
In: Clinical and Translational Allergy . (Clinical and Translational Allergy, March 2023, 13(3))
Subject
Language
English
ISSN
20457022